Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ISRCTN10201070) titled 'Study evaluating the effects of GOZEN BIOMATCHA(R) on vascular health' on March 12.
Study Type: Interventional
Study Design:
Allocation: Randomized controlled trial
Masking: Blinded (masking used)
Control: Placebo
Assignment: Parallel
Purpose: Treatment
Primary Sponsor: Gozen Biotech
Condition:
Mild subclinical cardiovascular dysfunction
Circulatory System
Intervention:
Participants are randomized in a 1:1 allocation ratio to receive either GOZEN BIOMATCHA(R) or a matched placebo in a double-blind, parallel-group design. Block randomization are used to allocate participants to each group.
GOZEN BIOMATCHA(...